Top Tech Companies (2,157)
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
Epocrates, an athenahealth service, is the #1 medical app among U.S. physicians. Over 1 million healthcare professionals trust Epocrates to help them make more confident, efficient decisions at the point of care. Clinicians rely on Epocrates drug monographs, interaction check, medical calculators and many other features throughout their daily workflows.
GoodRx helps Americans save on prescriptions. Americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. Even if you have insurance or Medicare. We offer a website and mobile apps that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US. GoodRx is used by thousands of physicians and millions of Americans each month. We have saved Americans over $3 billion. We're not going to rest until prescriptions are affordable for all Americans. We also offer GoodRx for Benefits, which provides technology solutions for health plans, payors and PBM's in an easy-to-understand website and mobile app experience. Learn more at www.goodrx.com/benefits.
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a GCLP complaint Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Inc. offers Next-Generation Sequencing based genomic solutions in cancer immunotherapy and metabolic diseases. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level, to facilitate research in personalized health care. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia, applying Next Generation Sequencing (NGS) techniques to large disease cohorts in cancer, eye and neurological disorders, diabetes, cardiovascular diseases and rare cancers. Our NGS lab in Bangalore is the highest throughput lab in South-East Asia. We offer more than 400 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases. MedGenome is the only NGS facility in the country to be validated and verified to run the highly accurate and comprehensive non-invasive prenatal test (Panorama). MedGenome has two state-of-the-art sequencing labs – A 10,000 sq. ft. in Bangalore and 5000 sq. ft. lab in Cochin – the only company in India to do so. MedGenome has recently purchased the Illumina NovaSeq platform to fuel its genomic research services capability. Our dedicated team of biologists, bioinformaticians and statisticians analyze omics data to enable research projects by global pharma and biotech.
Care at Hand (a wholly-owned subsidiary of Mindoula Health) is a Predictive Insights Platform Powered by Non-Medical Staff Mission: Care at Hand is a digital health company on a mission to ensure people can thrive in their homes and avoid unnecessary stays in hospitals. What we do: For payers and providers struggling to optimize margins and achieve the Triple Aim, Care at Hand provides a smart survey platform that identifies early medical and psychosocial risk factors for hospitalization. What makes us unique: Unlike episodic predictive models limited to claims and EMR data, Care at Hand predicts hospitalization risk in the blind spot between doctor visits using the observations of existing frontline staff. Evidence: $9,056 Medicare A savings per beneficiary per year (Avalere 2015). 39.6% reduction readmissions & 257% ROI (AHRQ 2014). Predict admissions up to 120 days (PHIM 2016).
Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms.
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and late preclinical development. Five Prime is committed to innovation and outstanding science to develop effective new drugs for the treatment of severe diseases. We value our culture of openness, collaboration and productivity.
Founded in 2013, we started Madison Reed with a simple mission: To make luxurious, at-home hair color with ingredients you can feel good about. At the forefront of innovation, we created the first ever smart 6-Free permanent hair color: Free of ammonia, parabens, resorcinol, PPD, phthalates and gluten. And we added hair-loving nutrients including keratin, argan oil, and ginseng root extract to protect and pamper hair. Madison Reed is revolutionizing the $50 billion hair care industry by making personal care more personal and by offering best-in-class products formulated under strict standards that truly raise the bar. Our deep commitment to the “client” experience paired with our dedication to technology and product innovation has fostered an extremely dedicated, consistently-growing fan base. We are a company built on integrity, innovation, responsibility and love. Headquartered in San Francisco’s colorful Mission neighborhood, our team is over 60+ strong. We are backed by leading investors such as: Norwest Partners, True Ventures, Comcast Ventures and Maveron.
International Biomedical Devices is an early-stage medical device company focused on ophthalmology innovations.
Honor, a home care company, is the founder of the Honor Care Network, a pioneering national network of home care providers. Honor is the first company ever to bring scalable workforce management and technology expertise together with the high-touch, personalized care of local homegrown care agencies. Working with Care Network Partners, Honor helps older adults live safely and comfortably in their own home by enabling reliable, transparent, high-quality care. Founded in 2015, Honor is now one of the fastest-growing, non-medical home care companies in the U.S., currently providing care to families in California, Texas, and New Mexico.
At Better we are united by our shared passion for outcomes that transform the human experience in healthcare. We are a group of clinicians and technologists who are developing prescription mobile applications for treating and reversing diseases like diabetes and high blood pressure. We believe software is on the verge of disrupting medicine and we are deeply committed to making sure the products we create for patients are useable, intuitive, intelligent and elegant. Our software has been validated through multiple clinical trials and we are beginning to commercialize with private health insurance companies while pursuing FDA approval. Our founding team has started, led and exited multiple technology companies that have transformed industries and generated billions of dollars in enterprise value. The 17th Surgeon General of the US, Dr. Richard Carmona, serves as an independent board director. We were founded in 2015; are headquartered in San Francisco, with operations in Boston, MA, and Nashville, TN.
Our company is committed to growing healthy families. We were born from the experiences of our founder and CEO, who struggled with her own high-risk pregnancy. Information was siloed, support was elusive and not personalized, and it was difficult to navigate the resources available to her. As an experienced healthcare executive, she decided to use her own journey as a catalyst for helping employers, health plans and hospitals improve the experience, and ultimately the health outcomes, of women and families across the country. Our first solution was a mobile app that helped women have healthy babies, digitally guiding them through their pregnancy journey, identifying risk, and connecting them with personalized care. Since then, we have contracted with organizations that cover nearly 50 million Americans and have grown from a pregnancy application into a digital solution that addresses evolving needs, from family planning to pregnancy to pediatrics and beyond. We empower women and their families to confidently navigate and access the care they need, when they need it. By deeply integrating our technology into healthcare and personalizing the user experience, we help the entire healthcare ecosystem meet the expectations of today’s consumer, driving a meaningful impact on health for entire families.
pMD provides intuitive, elegant mobile software that improves patient care and makes doctors and care teams happy. Our mobile communication and data capture platform vastly increases efficiency, improves collaboration, and allows doctors to capture more accurate information right at the point of care. With pMD, doctors can work easily to capture their billing charges, access information in real-time and communicate securely. Our mobile software eliminates tedious manual processes so that health care teams can focus on the issues that matter most and provide the best possible care for their patients.
Spruce is the leading platform for communication and care outside of the exam room. We’re committed to building quality healthcare experiences that are accessible anytime, anywhere. We’re backed by Kleiner Perkins Caufield & Byers and other top silicon valley investors and advisors and based in San Francisco, CA.
Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. The target has been validated in a number of animal models and Cortexyme is currently moving a proprietary small molecule towards human clinical testing.
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
CureJoy is a platform to concise natural health information about holistic therapies, alternate health supplements & whole food nutrition to achieve optimal health naturally, from our experts throughout the world. However, there are various alternative medical and healing therapies like Yoga, Ayurveda, Naturopathy, Homeopathy, Acupuncture etc, built on top of solid foundation and logic of having proven results for many decades. Most importantly, these remedies are based on nature and incorporate natural elements in their treatment. People have found cures for their chronic ailments through some of these alternative practices, being fruitless for their conventional medicine years together. CureJoy is an effort to bring the knowledge and reliable information about these alternative disciplines to the masses and help one make an informed healthcare decision. CureJoy enables one to connect with an expert in the concerned area of medicine and seek an honest and reliable advice to their problems. CureJoy ensures that experts on its platform are 100% qualified and meet all the standards and experience in providing a genuine and quality advice.
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 650 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Canada, Europe, Asia, and Latin America.
Standard Cyborg enables developers to build 3D scanning, analysis, and design into your digital and physical applications. standardcyborg.com Standard Cyborg is a YCombinator backed startup.
